Clinical Trial

AI-Assisted Written Information in Symptomatic Hemorrhoidal Disease

Study acronym: HD-AI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This single-center, prospective, parallel-group, 1:1 randomized controlled trial compares standardized verbal counseling with AI-assisted written patient information in adults with symptomatic hemorrhoidal disease receiving initial conservative/medical treatment. The primary objective is to determine whether AI-assisted written information improves complete treatment adherence at day 14. Secondary objectives include quality-of-life change, Patient Global Impression of Change, time to symptom improvement, change in pain/discomfort scores, change in bleeding, swelling, itching, and soiling symptoms, and unplanned repeat healthcare visits.
Trial Details
NCT Number NCT07701798
Lead Sponsor Sanliurfa Education and Research Hospital
Conditions Symptomatic Hemorrhoidal Disease, Hemorrhoids Grade I and II
Enrollment 220 participants
Start Date 2026-07-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14